PAID ADVERTISEMENT
Faculty:
Martha Grogan, MD, FACP, FACC
Marianna Fontana, MD
Nitasha Sarswat, MD
Learning Objectives:
After participating in this educational activity, participants should be better able to:
- Describe the pathophysiology and genetic variation of amyloid transthyretin amyloidosis with cardiomyopathy (ATTR-CM)
- Discuss the clinical manifestations and diagnosis of ATTR-CM
- Compare the treatment options available for patients with ATTR-CM
Attend our free CME dinner and enjoy the complete Philly experience as expert faculty openly discuss transthyretin amyloidosis cardiomyopathy (ATTR-CM) as a treatable condition and provide an updated review of the disease state and genetic variations. Enroll in this symposium for a chance to win a gift card provided by Medtelligence to create your own Philly experience!
TO REGISTER VISIT: reachmd.com/attr-cm/
This event is not part of the official Scientific Sessions 2023 as planned by the American Heart Association Committee on Scientific Sessions Program.
